Fastly (ticker: FSLY) insider files to sell 7,497 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A Form 144 notice for Fastly, Inc. reports a planned sale of 7,497 shares of common stock through E*TRADE Securities LLC on the Nasdaq exchange, with an approximate sale date of 02/18/2026. The shares are restricted stock acquired from Fastly on 02/15/2026, with payment also made on that date.
The filing also lists prior three-month sales by Scott Lovett, including 9,779 Class A common shares sold on 11/18/2025 for gross proceeds of 100,039.17, 34,517 shares sold on 12/16/2025 for 350,347.55, and 42,118 shares sold on 12/17/2025 for 425,391.8. The seller represents that they do not know of undisclosed material adverse information and references potential use of a Rule 10b5-1 trading plan.
Positive
- None.
Negative
- None.
FAQ
What insider transaction does Fastly (FSLY) Form 144 disclose?
The Form 144 discloses a planned sale of 7,497 shares of Fastly common stock. The shares will be sold through E*TRADE Securities LLC on Nasdaq, with an approximate sale date of February 18, 2026, and are classified as restricted stock acquired on February 15, 2026.
What are the gross proceeds from recent Fastly (FSLY) insider sales?
The notice shows gross proceeds of 100,039.17 from 9,779 shares sold on November 18, 2025. It also reports 350,347.55 from 34,517 shares sold on December 16, 2025, and 425,391.8 from 42,118 shares sold on December 17, 2025, all in Fastly Class A common stock.
What type of Fastly (FSLY) securities are covered by this Form 144?
The Form 144 covers common stock of Fastly, characterized as restricted shares acquired from Fastly, Inc. on February 15, 2026. The filing specifies common stock as the security class and identifies Nasdaq as the exchange where the planned sale through E*TRADE Securities LLC will occur.
What representations does the Fastly (FSLY) Form 144 filer make about nonpublic information?
The person for whose account the Fastly securities will be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed. The form also references potential use of a written Rule 10b5-1 trading plan.